NUTX vs MD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 24, 2026

NUTX

53.5
AI Score
VS
NUTX Wins

MD

52.5
AI Score

Investment Advisor Scores

NUTX

54score
Recommendation
HOLD

MD

53score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric NUTX MD Winner
Forward P/E 0 8.2102 Tie
PEG Ratio 0 0.2433 Tie
Revenue Growth 2.2% 3.9% MD
Earnings Growth 95.9% 50.0% NUTX
Tradestie Score 53.5/100 52.5/100 NUTX
Profit Margin 10.9% 9.0% NUTX
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

NUTX 1M: -22.7% · 3M: +23.7% MD 1M: +1.4% · 3M: +17.8%

Current Technical Phase

NUTX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 42

RSI (14): 42.4 · Price: $147.43

MD

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (5.9% over 20 days), RSI 57

RSI (14): 57.0 · Price: $26.51

Fundamentals Snapshot

Metric NUTX MD
Market Cap
Forward P/E 6.4 11.3
Trailing P/E 10.9 12.7
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin 0.5% 0.3%
Operating Margin 0.4% 0.1%
EPS 13.67 2.12
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, NUTX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.